357 related articles for article (PubMed ID: 32740646)
21. Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.
Gong Q; Wan Q; Li A; Yu Y; Ding X; Lin L; Qi X; Hu L
Aging (Albany NY); 2020 Oct; 12(20):20254-20267. PubMed ID: 33100273
[TBL] [Abstract][Full Text] [Related]
22. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer.
Wang F; Chen C; Chen WP; Li ZL; Cheng H
Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125
[TBL] [Abstract][Full Text] [Related]
23. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
Ma B; Li Y; Ren Y
Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
[TBL] [Abstract][Full Text] [Related]
24. Development and Validation of a Scoring System Based on 9 Glycolysis-Related Genes for Prognosis Prediction in Gastric Cancer.
Luo T; Du Y; Duan J; Liang C; Chen G; Jiang K; Chen Y; Chen Y
Technol Cancer Res Treat; 2020; 19():1533033820971670. PubMed ID: 33161837
[TBL] [Abstract][Full Text] [Related]
25. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatics Analysis Reveals Prognostic Significance of the Macrophage Marker Gene Signature in Gastric Adenocarcinoma.
Li Z; Chen H; Chen Z; Xie L; Pan D
Front Biosci (Landmark Ed); 2024 May; 29(5):172. PubMed ID: 38812299
[TBL] [Abstract][Full Text] [Related]
27. A signature of tumor immune microenvironment genes associated with the prognosis of non‑small cell lung cancer.
Li J; Li X; Zhang C; Zhang C; Wang H
Oncol Rep; 2020 Mar; 43(3):795-806. PubMed ID: 32020214
[TBL] [Abstract][Full Text] [Related]
28. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
29. Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer.
Qiu F; Zhu Y; Shi Y; Ji J; Jin Y
Dis Markers; 2021; 2021():4251763. PubMed ID: 34804261
[TBL] [Abstract][Full Text] [Related]
30. Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma.
Chen D; Huang H; Zang L; Gao W; Zhu H; Yu X
Front Immunol; 2021; 12():728062. PubMed ID: 34691034
[TBL] [Abstract][Full Text] [Related]
31. A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.
Peng K; Chen E; Li W; Cheng X; Yu Y; Cui Y; Li Q; Wang Y; Xu X; Tang C; Gan L; Yu S; Liu T
J Cell Physiol; 2020 Jul; 235(7-8):5777-5786. PubMed ID: 32048287
[TBL] [Abstract][Full Text] [Related]
32. Identification of Prognosis-Related Genes in Bladder Cancer Microenvironment across TCGA Database.
Zhao X; Tang Y; Ren H; Lei Y
Biomed Res Int; 2020; 2020():9143695. PubMed ID: 33204728
[TBL] [Abstract][Full Text] [Related]
33. Quantitative proteomics identified 3 oxidative phosphorylation genes with clinical prognostic significance in gastric cancer.
Su F; Zhou FF; Zhang T; Wang DW; Zhao D; Hou XM; Feng MH
J Cell Mol Med; 2020 Sep; 24(18):10842-10854. PubMed ID: 32757436
[TBL] [Abstract][Full Text] [Related]
34. Prognosis genes in gastric adenocarcinoma identified by cross talk genes in disease‑related pathways.
Zhao L; Lei H; Shen L; Tang J; Wang Z; Bai W; Zhang F; Wang S; Li W
Mol Med Rep; 2017 Aug; 16(2):1232-1240. PubMed ID: 28586067
[TBL] [Abstract][Full Text] [Related]
35. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
[No Abstract] [Full Text] [Related]
36. A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer.
Jiang H; Gu J; Du J; Qi X; Qian C; Fei B
Mol Med Rep; 2020 Jan; 21(1):347-359. PubMed ID: 31939629
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
38. A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma.
Xue Y; Li J; Lu X
Technol Cancer Res Treat; 2020; 19():1533033820935860. PubMed ID: 32588760
[TBL] [Abstract][Full Text] [Related]
39. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
Hu C; Zhou Y; Liu C; Kang Y
Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
[TBL] [Abstract][Full Text] [Related]
40. Identification of Key Genes of Prognostic Value in Clear Cell Renal Cell Carcinoma Microenvironment and a Risk Score Prognostic Model.
Zhao E; Bai X
Dis Markers; 2020; 2020():8852388. PubMed ID: 32952743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]